T-cell acute lymphoblastic leukemia, not otherwise specified
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
T-cells
|
| gptkbp:associated_with |
lymphadenopathy
splenomegaly central nervous system involvement |
| gptkbp:can_lead_to |
gptkb:healthcare_organization
acute respiratory distress syndrome organ failure |
| gptkbp:clinical_trial |
gptkb:vaccine
ongoing research targeted therapy new therapies |
| gptkbp:events |
rehabilitation services
regular monitoring supportive care psychosocial support |
| gptkbp:genetic_diversity |
gptkb:physicist
FBX W7 mutation NOTC H1 mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
T-cell acute lymphoblastic leukemia, not otherwise specified
|
| gptkbp:is_a |
hematologic malignancy
|
| gptkbp:is_characterized_by |
bone marrow infiltration
extramedullary disease lymphoid tissue involvement rapid proliferation of T-lymphoblasts |
| gptkbp:is_often_used_in |
gptkb:Person
young adults |
| gptkbp:rarity |
elderly
|
| gptkbp:risk_factor |
genetic mutations
certain chemicals exposure to radiation |
| gptkbp:social_responsibility |
blood tests
varies by age bone marrow biopsy varies by treatment response |
| gptkbp:symptoms |
gptkb:fandom
fatigue fever bleeding |
| gptkbp:treatment |
gptkb:drug
varies by individual chemotherapy remission stem cell transplant depends on disease stage depends on genetic factors |
| gptkbp:type_of |
gptkb:healthcare_organization
gptkb:T-cell_neoplasm |
| gptkbp:bfsParent |
gptkb:ALK
|
| gptkbp:bfsLayer |
5
|